Open Access Mini Review

New Treatment New Complication – Mini Review

Ákos Géza Pethő*

Semmelweis University, Faculty of Medicine 1083 Budapest, Hungary

Corresponding Author

Received Date: May 15, 2020;  Published Date: June 29, 2020

Abstract

Nephrotoxicity caused by medication could limit the treatment success. In multiple malignancies are playing crucial role the anti-cancer drugs which have well known nephrotoxicity. Using the conventional chemotherapies acute kidney injury could develop but not in all patients who are suffering cancers. In these patients will acute tubulointerstitial nephritis or rarely nephrotic syndrome occur. The onco-pharmacology is an intensively investigated field. In the recent decade’s novel therapies founded. The new treatments in oncology have more targeted affect on cancer cells. These drugs will be modifying the whole immune system with the fine balance between cancer surveillance and preserving self-tolerance. The immune checkpoint inhibitors have superior anti-cancer therapeutic affect but new, until unknown complication raised. In this mini review we will discuss the most acute kidney injuries during chemotherapy.

Keywords: Cancer; Chemotherapy; Immune system; Immune checkpoint inhibitors

Citation
Signup for Newsletter
Scroll to Top